RaySearch Laboratories AB (publ) (STO:RAY.B)
Sweden
· Delayed Price · Currency is SEK | Market Cap | 7.70B |
| Revenue (ttm) | 1.29B |
| Net Income (ttm) | 219.21M |
| Shares Out | 34.28M |
| EPS (ttm) | 6.39 |
| PE Ratio | 35.11 |
| Forward PE | 26.95 |
| Dividend | 3.00 (1.34%) |
| Ex-Dividend Date | n/a |
| Volume | 427,711 |
| Average Volume | 161,739 |
| Open | 225.00 |
| Previous Close | 225.00 |
| Day's Range | 223.00 - 230.00 |
| 52-Week Range | 195.00 - 373.50 |
| Beta | 1.21 |
| RSI | 47.80 |
| Earnings Date | Nov 7, 2025 |
About RaySearch Laboratories AB
RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. The company offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems. It also provides µ-RayStation... [Read more]
Financial Performance
In 2024, RaySearch Laboratories AB's revenue was 1.19 billion, an increase of 16.62% compared to the previous year's 1.02 billion. Earnings were 203.51 million, an increase of 149.49%.
Financial StatementsNews
RaySearch Laboratories AB (RSLBF) Q3 2025 Earnings Call Highlights: Record Sales and Strong ...
RaySearch Laboratories AB (RSLBF) Q3 2025 Earnings Call Highlights: Record Sales and Strong Order Intake Amid Cash Flow Challenges
Q3 2025 RaySearch Laboratories AB (publ) Earnings Call Transcript
Q3 2025 RaySearch Laboratories AB (publ) Earnings Call Transcript
RaySearch Laboratories AB (publ) 2025 Q3 - Results - Earnings Call Presentation
RaySearch Laboratories AB (publ) (RSLBF) Q3 2025 Earnings Call Transcript
Q2 2025 RaySearch Laboratories AB (publ) Earnings Call Transcript
Q2 2025 RaySearch Laboratories AB (publ) Earnings Call Transcript
Q1 2025 RaySearch Laboratories AB (publ) Earnings Call Transcript
Q1 2025 RaySearch Laboratories AB (publ) Earnings Call Transcript
RaySearch Laboratories GAAP EPS of SEK0.90, revenue of SEK304.9M
RaySearch Laboratories: Interim report April - June 2025
STOCKHOLM , Aug. 8, 2025 /PRNewswire/ -- SECOND QUARTER (APRIL - JUNE 2025) Order intake amounted to SEK 241.2 M (290.3) Net sales amounted to SEK 304.9 (318.9) Operating profit amounted to SEK 36.4 M...
Invitation to presentation of RaySearch's interim report for the second quarter of 2025
STOCKHOLM , July 18, 2025 /PRNewswire/ -- Analysts, investors, and the media are invited to a presentation of RaySearch's interim report for the second quarter of 2025, on August 8, 2025, at 10.00 am ...
RaySearch Laboratories reports interim report for January 1 to March 31, 2025
Interim report January 1 - March 31, 2025: RaySearch Laboratories
STOCKHOLM , May 9, 2025 /PRNewswire/ -- FIRST QUARTER (JANUARY - MARCH 2025) Order intake amounted to SEK 409.6 M (238.5) Net sales amounted to SEK 331.7 M (257.2) Operating profit amounted to SEK 74...
RaySearch Laboratories and Vision RT present innovations in surface guided treatment planning at ESTRO
STOCKHOLM , May 3, 2025 /PRNewswire/ -- At this week's ESTRO conference in Vienna, RaySearch Laboratories AB (publ) and Vision RT proudly announces the next step in their collaboration: the full integ...
Invitation to presentation of RaySearch's interim report for the first quarter of 2025
STOCKHOLM , April 25, 2025 /PRNewswire/ -- Analysts, investors, and the media are invited to a presentation of RaySearch's interim report for the first quarter of 2025, on May 9, 2025, at 10.00 am CES...
Completed placing of shares in RaySearch Laboratories AB (publ)
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION ...
Contemplated placement of existing shares in RaySearch Laboratories AB
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION ...
RaySearch Laboratories reports Q4 results
RaySearch Laboratories: Year-end report 2024
STOCKHOLM , Feb. 21, 2025 /PRNewswire/ -- FOURTH QUARTER (OCTOBER - DECEMBER 2024) Order intake SEK 305.0 M (317.7) Net sales SEK 322.7 (299.6) Operating profit SEK 73.6 M (44.4) Profit after tax SEK...
RaySearch Laboratories to present ongoing development in liver ablation therapy* at RSNA 2024
STOCKHOLM , Nov. 29, 2024 /PRNewswire/ -- RaySearch will be exhibiting its advanced software solutions at RSNA in Chicago, Illinois, December 1 – 4. RSNA is the largest conference show in the field of...
RaySearch Laboratories AB (RSLBF) Q3 2024 Earnings Call Highlights: Record Revenue and ...
RaySearch Laboratories AB (RSLBF) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Initiatives
Q3 2024 RaySearch Laboratories AB (publ) Earnings Call Transcript
Q3 2024 RaySearch Laboratories AB (publ) Earnings Call Transcript
RaySearch Laboratories: Interim report July - September 2024
STOCKHOLM , Nov. 8, 2024 /PRNewswire/ -- THIRD QUARTER (JULY - SEPTEMBER 2024) Order intake SEK 253.4 M (240.7) Net sales SEK 293.3 (252.9) Operating profit SEK 61.8 M (28,6) Profit after tax SEK 45....
RaySearch Laboratories: Interim report April - June 2024
STOCKHOLM , Aug. 16, 2024 /PRNewswire/ -- SECOND QUARTER (APRIL- JUNE 2024) Order intake SEK 290.3 M (239.2) Net sales SEK 318.9 M (239.5) Operating profit SEK 79.3 M (18.2) Profit after tax SE...
Invitation to presentation of RaySearch's interim report for the second quarter of 2024
STOCKHOLM , Aug. 9, 2024 /PRNewswire/ -- Analysts, investors, and the media are invited to a presentation of RaySearch's interim report for the second quarter of 2024 on August 16, 2024, at 10.00 am C...
RaySearch Laboratories: Interim report January 1 - March 31, 2024
STOCKHOLM , May 17, 2024 /PRNewswire/ -- FIRST QUARTER (JANUARY - MARCH 2024) Oder intake SEK 238.5 M (206.6) Net sales SEK 257.2 M (230.2) Operating profit SEK 45.8 M (23.7) Profit after tax SEK 36.7...
Invitation to presentation of RaySearch's interim report for the first quarter of 2024
STOCKHOLM , May 2, 2024 /PRNewswire/ -- Analysts, investors, and the media are invited to a presentation of RaySearch's interim report for the first quarter of 2024 on May 17, 2024, at 10.00 am CEST. ...